• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

RCT Results: Outpatient Balloon Catheter vs Inpatient Prostaglandin E2 for Induction of Labor

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Beckmann et al. (BJOG, 2020) compared clinical outcomes following labor induction using outpatient balloon catheter vs inpatient prostaglandin (PG)

METHODS:

  • Pragmatic multicenter randomized controlled trial RCT
  • Participants
    • Uncomplicated, cephalic, ≥37w0d, singleton pregnancies undergoing IOL for low-risk indications including
      • Post-term | Advanced maternal age | “Social” reasons
  • Exclusion
    • Congenital anomalies | Complicated pregnancies (e.g. SGA) | Previous Cesarean | Modified Bishops Score (MBS) ≥7
  • Interventions (all women had NST prior to intervention)
    • Use of balloon catheter for IOL as an outpatient
      • Double-balloon catheter inserted (80 ml saline instillation) and sent home following 30 minute observation period
      • Post-insertion NST not routinely performed prior to discharge home
      • Returned in 12 hours for follow up and review
    • Use of PG for IOL as an inpatient (Obstetrician choice of PG)
      • 2 mg dinoprostone vaginal gel (Prostin) or 10 mg dinoprostone controlled-release vaginal tape (Cervidil)
  • Primary outcome: Composite neonatal measure ≥1 of the following
    • Nursery admission | Intubation | Cardiac compressions | Acidemia (cord pH <7.10) | HIE | Seizure | Infection | Pulmonary hypertension | Stillbirth | Death
  • Secondary outcomes
    • Included mode of birth, pain scores and duration of labor were also evaluated
  • Statistical analysis
    • Sample size required: 2500
    • To detect a 31% reduction in the composite neonatal outcome (10.0% to 6.9%)
    • 80% power 80% and type 1 error of 0.05

RESULTS:

  • 695 participants included | Study stopped at time of interim analysis by Data and Safety Monitoring Committee due to (1) slow rate of recruitment (2) loss of patients from time of consent to randomization and (3) very low rates of adverse outcomes
    • Balloon group: 347 women
    • PG group: 348 women
  • There were no significant differences for the following
    • Composite neonatal measure
      • Balloon: 18.6%
      • PG: 25.8%
      • Relative risk (RR) 0.77 (95% CI 0.51 to 1.02; P=0.070)
    • Cord arterial pH <7.10 (P=0.072)
      • Balloon: 3.5%
      • PG: 9.2%
    • Nursery admissions (P=0.379)
      • Balloon: 12.6%
      • PG: 15.5%
    • Neonatal antibiotic use (P=0.103)
      • Balloon: 12.1%
      • PG: 17.6%
    • Cesarean delivery (P=0.240)
      • Balloon: 32.6%
      • PG: 25.8%
  • Nulliparous women in the balloon group had lower rates of the primary outcome (P=0.032)
    • Balloon: 20.4%
    • PG: 31.0%
  • Parous women in the balloon group were less likely to have an unassisted vaginal birth (P=0.045)
    • Balloon: 77.6%
    • PG: 92.3%
  • Parous women with a favorable cervix and in the balloon group had higher rates of cesarean than those in the PG group (21.2% vs 2.4%; P =0.009)
  • No differences were detected for other secondary outcomes such as
    • PPH | Analgesic use | Maternal antibiotic use | Cord prolapse | Meconium stained fluid
    • Uterine hyperstimulation: Only occurred in the PG group (3.0% versus 0%; P =0.029)
  • Only 6% of women in the balloon arm returned to hospital because of labor onset

CONCLUSION:

  • Outpatient balloon catheter for IOL may be superior to inpatient PG for nulliparous women resulting in decreased composite adverse neonatal outcomes
  • For parous women, similar benefits were not seen and there may be increased risk for cesarean with a favorable cervix

Learn More – Primary Sources:

Induction of labour using prostaglandin E2 as an inpatient versus balloon catheter as an outpatient: a multicentre randomised controlled trial

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Cochrane Review 2017: Outpatient Cervical Ripening and Labor Induction
Outpatient Balloon Catheters for Labor Induction – Assessment of Potential Risks?
Foley vs Misoprotol:  What is the Most Cost-Effective Way to Induce Labor?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site